Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Treatment Adherence and Support for People who Inject Drugs Taking Direct Acting Antiviral Therapy for Hepatitis C Infection.

Read P, Gilliver R, Kearley J, Lothian R, Cunningham EB, Chronister KJ, Dore GJ.

J Viral Hepat. 2019 Jul 12. doi: 10.1111/jvh.13175. [Epub ahead of print]

PMID:
31299127
2.

Feasibility and acceptability of adherence support for direct acting antiviral therapy for hepatitis C in a low-threshold primary health-care opioid agonist treatment program.

Chronister KJ, Lothian R, Gilliver R, Kearley J, Read P.

Drug Alcohol Rev. 2019 Feb;38(2):185-189. doi: 10.1111/dar.12903. Epub 2019 Feb 13.

PMID:
30761640
3.

Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting.

Read P, Lothian R, Chronister K, Gilliver R, Kearley J, Dore GJ, van Beek I.

Int J Drug Policy. 2017 Sep;47:209-215. doi: 10.1016/j.drugpo.2017.05.032. Epub 2017 Jun 4.

PMID:
28587943
4.

Erratum: Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs.

Silver JS, Kearley J, Copenhaver AM, Sanden C, Mori M, Yu L, Pritchard GH, Berlin AA, Hunter CA, Bowler R, Erjefalt JS, Kolbeck R, Humbles AA.

Nat Immunol. 2016 Jul 19;17(8):1005. doi: 10.1038/ni0816-1005c. No abstract available.

PMID:
27434015
5.

Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs.

Silver JS, Kearley J, Copenhaver AM, Sanden C, Mori M, Yu L, Pritchard GH, Berlin AA, Hunter CA, Bowler R, Erjefalt JS, Kolbeck R, Humbles AA.

Nat Immunol. 2016 Jun;17(6):626-35. doi: 10.1038/ni.3443. Epub 2016 Apr 25. Erratum in: Nat Immunol. 2016 Jul 19;17 (8):1005.

6.

Altered expression of the CCN genes in the lungs of mice in response to cigarette smoke exposure and viral and bacterial infections.

Gueugnon F, Thibault VC, Kearley J, Petit-Courty A, Vallet A, Guillon A, Si-Tahar M, Humbles AA, Courty Y.

Gene. 2016 Jul 15;586(1):176-83. doi: 10.1016/j.gene.2016.04.022. Epub 2016 Apr 11.

PMID:
27080955
7.

Findings and lessons learnt from implementing Australia's first health service based take-home naloxone program.

Chronister KJ, Lintzeris N, Jackson A, Ivan M, Dietze PM, Lenton S, Kearley J, van Beek I.

Drug Alcohol Rev. 2018 May;37(4):464-471. doi: 10.1111/dar.12400. Epub 2016 Apr 13.

PMID:
27071354
8.

Cigarette smoke silences innate lymphoid cell function and facilitates an exacerbated type I interleukin-33-dependent response to infection.

Kearley J, Silver JS, Sanden C, Liu Z, Berlin AA, White N, Mori M, Pham TH, Ward CK, Criner GJ, Marchetti N, Mustelin T, Erjefalt JS, Kolbeck R, Humbles AA.

Immunity. 2015 Mar 17;42(3):566-79. doi: 10.1016/j.immuni.2015.02.011.

9.

IL-33 drives airway hyper-responsiveness through IL-13-mediated mast cell: airway smooth muscle crosstalk.

Kaur D, Gomez E, Doe C, Berair R, Woodman L, Saunders R, Hollins F, Rose FR, Amrani Y, May R, Kearley J, Humbles A, Cohen ES, Brightling CE.

Allergy. 2015 May;70(5):556-67. doi: 10.1111/all.12593. Epub 2015 Mar 16.

10.

Opposing roles of membrane and soluble forms of the receptor for advanced glycation end products in primary respiratory syncytial virus infection.

Miller AL, Sims GP, Brewah YA, Rebelatto MC, Kearley J, Benjamin E, Keller AE, Brohawn P, Herbst R, Coyle AJ, Humbles AA, Kolbeck R.

J Infect Dis. 2012 Apr 15;205(8):1311-20. doi: 10.1093/infdis/jir826. Epub 2012 Jan 18.

11.

IL-9 governs allergen-induced mast cell numbers in the lung and chronic remodeling of the airways.

Kearley J, Erjefalt JS, Andersson C, Benjamin E, Jones CP, Robichaud A, Pegorier S, Brewah Y, Burwell TJ, Bjermer L, Kiener PA, Kolbeck R, Lloyd CM, Coyle AJ, Humbles AA.

Am J Respir Crit Care Med. 2011 Apr 1;183(7):865-75. doi: 10.1164/rccm.200909-1462OC. Epub 2010 Oct 22.

12.

Nonredundant role of CCRL2 in lung dendritic cell trafficking.

Otero K, Vecchi A, Hirsch E, Kearley J, Vermi W, Del Prete A, Gonzalvo-Feo S, Garlanda C, Azzolino O, Salogni L, Lloyd CM, Facchetti F, Mantovani A, Sozzani S.

Blood. 2010 Oct 21;116(16):2942-9. doi: 10.1182/blood-2009-12-259903. Epub 2010 Jul 6.

13.

Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression.

Campbell JD, Buckland KF, McMillan SJ, Kearley J, Oldfield WL, Stern LJ, Grönlund H, van Hage M, Reynolds CJ, Boyton RJ, Cobbold SP, Kay AB, Altmann DM, Lloyd CM, Larché M.

J Exp Med. 2009 Jul 6;206(7):1535-47. doi: 10.1084/jem.20082901. Epub 2009 Jun 15.

14.

Glycerol-3-phosphate acyltransferases gat1p and gat2p are microsomal phosphoproteins with differential contributions to polarized cell growth.

Bratschi MW, Burrowes DP, Kulaga A, Cheung JF, Alvarez AL, Kearley J, Zaremberg V.

Eukaryot Cell. 2009 Aug;8(8):1184-96. doi: 10.1128/EC.00085-09. Epub 2009 Jun 12.

15.

Capillary defects and exaggerated inflammatory response in the airways of EphA2-deficient mice.

Okazaki T, Ni A, Baluk P, Ayeni OA, Kearley J, Coyle AJ, Humbles A, McDonald DM.

Am J Pathol. 2009 Jun;174(6):2388-99. doi: 10.2353/ajpath.2009.080949. Epub 2009 May 14.

16.

Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis.

Lee CG, Hartl D, Lee GR, Koller B, Matsuura H, Da Silva CA, Sohn MH, Cohn L, Homer RJ, Kozhich AA, Humbles A, Kearley J, Coyle A, Chupp G, Reed J, Flavell RA, Elias JA.

J Exp Med. 2009 May 11;206(5):1149-66. doi: 10.1084/jem.20081271. Epub 2009 May 4.

17.

Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway.

Kearley J, Buckland KF, Mathie SA, Lloyd CM.

Am J Respir Crit Care Med. 2009 May 1;179(9):772-81. doi: 10.1164/rccm.200805-666OC. Epub 2009 Jan 29.

18.

CD4+CD25+ regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling.

Kearley J, Robinson DS, Lloyd CM.

J Allergy Clin Immunol. 2008 Sep;122(3):617-24.e6. doi: 10.1016/j.jaci.2008.05.048. Epub 2008 Jul 30.

19.

Strain-specific requirement for eosinophils in the recruitment of T cells to the lung during the development of allergic asthma.

Walsh ER, Sahu N, Kearley J, Benjamin E, Kang BH, Humbles A, August A.

J Exp Med. 2008 Jun 9;205(6):1285-92. doi: 10.1084/jem.20071836. Epub 2008 May 19.

20.

Th2-driven, allergen-induced airway inflammation is reduced after treatment with anti-Tim-3 antibody in vivo.

Kearley J, McMillan SJ, Lloyd CM.

J Exp Med. 2007 Jun 11;204(6):1289-94. Epub 2007 May 21.

21.

Y-chromosomal insights into the genetic impact of the caste system in India.

Zerjal T, Pandya A, Thangaraj K, Ling EY, Kearley J, Bertoneri S, Paracchini S, Singh L, Tyler-Smith C.

Hum Genet. 2007 Mar;121(1):137-44. Epub 2006 Oct 31.

22.

Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent.

Kearley J, Barker JE, Robinson DS, Lloyd CM.

J Exp Med. 2005 Dec 5;202(11):1539-47. Epub 2005 Nov 28.

23.

Matrix metalloproteinase-9 deficiency results in enhanced allergen-induced airway inflammation.

McMillan SJ, Kearley J, Campbell JD, Zhu XW, Larbi KY, Shipley JM, Senior RM, Nourshargh S, Lloyd CM.

J Immunol. 2004 Feb 15;172(4):2586-94.

Supplemental Content

Loading ...
Support Center